LLY
$77.80
Eli Lilly
($2.89)
(3.58%)
LLY
Earnings Whisper ®
N/A
3rd Quarter September 2017
Consensus:  $1.03
Revenue:  $5.51 Bil
Tuesday
Oct 24
6:25 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LLY reports earnings?
Beat
Meet
Miss

Where is LLY's stock price going from here?
Up
Flat
Down
Stock chart of LLY
Analysts
Summary of analysts' recommendations for LLY
Score
Grade
Pivots
Resistance
$82.55
$81.56
$79.68

$78.69

Support
$76.81
$75.82
$73.94
Tweet
Growth
Description
Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
Peers
Regeneron PharmaceuticalsCelgeneVertex PharmaceuticalsBioMarin PharmaceuticalZoetisEndo International plcJohnson & JohnsonPfizerUltragenyx PharmaceuticalBristol-Myers Squibb